Xu Wang has extensive experience in oncology business development, commercial strategy, and competitive intelligence. They served as the Head of Strategy and Market Intelligence at Merck Group from 2018 to 2020, followed by a role in Competitive Intelligence for Corporative Development and Commercialization at Gilead from 2020 to 2021. Currently, Xu is the Analytics, Forecast, and Insights Lead at AstraZeneca. Xu earned a Master of Business Administration (MBA) from NYU Stern School of Business between 2015 and 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices